We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New RNA Detection Tool Shows Promise for HIV and Other Viral Testing

By LabMedica International staff writers
Posted on 14 Oct 2026

RNA viruses such as human immunodeficiency virus (HIV) require assays that can detect very low levels of viral genetic material. More...

Clinical and environmental testing can also expose enzymes to harsh assay conditions, including high temperatures. This creates a need for detection components that combine sensitivity with stability. New research demonstrates an engineered Cas13a enzyme optimized to meet both requirements in RNA detection assays.

Rice University (Houston, TX, USA) scientists developed an improved version of Cas13a, a CRISPR-associated enzyme that targets RNA rather than DNA. In a detection assay, Cas13a binds to a target RNA sequence, such as RNA from HIV or SARS-CoV-2, and generates a signal that a person or instrument can read. To develop the improved enzyme, the team began with a stable Cas13a variant that could tolerate harsh assay conditions but lacked the sensitivity needed to detect very small quantities of target RNA.

To understand how to improve sensitivity while preserving stability, the researchers first resolved the protein’s structure. This required overcoming a technical challenge: Cas13a moves substantially as it binds RNA. The team therefore devised a way to hold the CRISPR/Cas13a system and its target RNA in place while collecting structural information. The resulting structure revealed two regions of the enzyme that the researchers believed could be modified to increase sensitivity.

Guided by these structural findings, the team engineered the two regions and tested the modified enzymes in the laboratory. Altering both regions made the enzyme overly sensitive, triggering signals even when target RNA was absent. Modifying just one region, however, increased sensitivity 100-fold without compromising stability. This engineered Cas13a variant also demonstrated a 100-fold performance improvement in a detection assay using a synthetic, noninfectious HIV sample.

The study was published in Cell Chemical Biology on October 13, 2026. The same Cas13a enzyme can be paired with a programmable guide designed to target different RNA sequences. According to the source, the guide could be reprogrammed for SARS-CoV-2, influenza virus, Ebola virus, Zika virus, respiratory syncytial virus or hepatitis C virus, and the enzyme could potentially be used in commercial assays such as reverse transcription quantitative PCR (RT-qPCR) and lateral flow testing.

“Any enzyme used in an assay needs to be both sensitive and stable. It needs to be able to detect very small amounts of RNA while enduring harsh conditions, like high temperatures. Here, we took a stable Cas13a and engineered it to have the desired sensitivity,” said Yang Gao, associate professor of biosciences at Rice University and corresponding author.

“In a CRISPR system, the enzyme is paired with a guide that targets a particular sequence of RNA. The guide is easy to program, so the critical part of the system is having an enzyme that’s compatible with your assays. Our version of Cas13a is optimized for sensitive and stable RNA detection assays and could potentially be used in commercial assays like RT-qPCR and lateral flow,” added Gao.

Related Links
Rice University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
HPV Test
Allplex HPV28 Detection
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The MIRAM GAGome Kit quantifies urine CS disaccharides by UHPLC-MS/MS, supporting exploratory and translational research across disease areas. (Photo courtesy of Elypta)

Study Finds Urine Biomarker Score Improves Five-Year Cancer Risk Prediction

Cancer risk stratification in healthy adults often relies on established factors such as age and smoking history. However, several cancers highlighted in the study, including pancreatic, kidney, and brain... Read more

Hematology

view channel
Image: These new ANC reference ranges can help clinicians more accurately interpret neutrophil counts, reduce unnecessary testing and treatment interruptions, and help support more equitable care. (Photo courtesy of the American Society of Hematology)

New Reference Ranges Clarify Normal Neutrophil Counts in Duffy-Null Patients

Duffy-null status is a common genetic trait associated with naturally lower circulating white blood cell counts. It affects about 10% of the U.S. population and more than 66% of people with African or... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: VITEK PRO combines microbial identification and antimicrobial susceptibility testing on a single platform to support routine microbiology workflows and antibiotic selection. (Photo courtesy of bioMérieux)

Automated Microbial Identification and Susceptibility System Gains FDA Clearance

Antimicrobial resistance (AMR) is a leading global public health threat, causing an estimated 1.27 million deaths annually. The growing challenge of diagnosing and treating resistant infections highlights... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: The collaboration aims to expand access to the technology through a regulated clinical diagnostics pathway in Japan.

Partnership Aims to Bring Blood-Based Alzheimer’s Testing to Japan

Alzheimer’s disease remains a growing diagnostic challenge as populations age and cognitive impairment becomes more common. In Japan, government-supported estimates project that approximately 4.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.